Literature DB >> 9601576

Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine.

M Arras1, R Strasser, M Mohri, R Doll, P Eckert, W Schaper, J Schaper.   

Abstract

The time course of expression of TNF-alpha in myocardial wound healing following ischemic injury was investigated in the porcine heart. Microembolization was used to induce focal ischemia and necrosis in hearts of 39 adult pigs. The animals were sacrificed after 3, 6, 12, 24 h, 3 and 7 days, and after 4 weeks, and the myocardial tissue was studied by immunofluorescence using specific antibodies. TNF-alpha containing cells were identified as monocytes/macrophages by double staining with a muramidase antibody. Monocytes/macrophages were the only source of TNF-alpha. Microembolization caused multiple necrotic foci with loss of myocytes in the left ventricular myocardium. These foci contained numerous monocytes/macrophages and showed an inflammatory reaction typical of wound healing followed by replacement with scar tissue. The number of TNF-alpha positive cells increased after 24 h, peaked between 3-7 days and slowly decreased thereafter. Expression of TNF-alpha in monocytes/macrophages was significantly reduced after pretreatment of pigs with cyclosporine or dexamethasone. It is concluded that 1.) in myocardial tissue monocytes/macrophages are the only cell type expressing TNF-alpha, 2.) TNF-alpha is involved in wound healing after ischemia, and 3.) synthesis of TNF-alpha and inflammatory angiogenesis can be inhibited be treatment with either cyclosporine or dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601576     DOI: 10.1007/s003950050069

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  19 in total

Review 1.  Control of apoptosis of cardiovascular fibroblasts: a novel drug target.

Authors:  H Rupp; B Maisch
Journal:  Herz       Date:  1999-05       Impact factor: 1.443

2.  Pathophysiology of coronary microembolisation.

Authors:  G Heusch; R Schulz
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

3.  Percutaneous microembolization of the left coronary artery to model ischemic heart disease in rats.

Authors:  Allard Wagenaar; Rob F Wiegerinck; Viviane V T Heijnen; Mark J Post
Journal:  Lab Anim (NY)       Date:  2016-01       Impact factor: 12.625

Review 4.  Targeting angiogenesis to restore the microcirculation after reperfused MI.

Authors:  Anja M van der Laan; Jan J Piek; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2009-06-16       Impact factor: 32.419

5.  Altered expression of pro- and anti-inflammatory cytokines is associated with reduced cardiac function in rats following coronary microembolization.

Authors:  Lang Li; Xianming Zhao; Yongguang Lu; Weiqiang Huang; Weiming Wen
Journal:  Mol Cell Biochem       Date:  2010-07-13       Impact factor: 3.396

Review 6.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

7.  Fibronectin fragments modulate monocyte VLA-5 expression and monocyte migration.

Authors:  J Trial; R E Baughn; J N Wygant; B W McIntyre; H H Birdsall; K A Youker; A Evans; M L Entman; R D Rossen
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

8.  Pathological observation of acute myocardial infarction in Chinese miniswine.

Authors:  Chuang Wang; Shao-Xin Wang; Ping-Shuan Dong; Li-Ping Wang; Na-Na Duan; Yan-Yu Wang; Ke Wang; Zhuan-Zhen Li; Li-Juan Wei; Ya-Li Meng; Jian-Xin Cheng
Journal:  Int J Clin Exp Med       Date:  2015-11-15

9.  Inflammation and ischemia: macrophages activated by fibronectin fragments enhance the survival of injured cardiac myocytes.

Authors:  JoAnn Trial; Roger D Rossen; Jose Rubio; Anne A Knowlton
Journal:  Exp Biol Med (Maywood)       Date:  2004-06

10.  Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Andrea Baumgartner; Matthias Hasun; Gregor Werba; Lucian Beer; Patrick Altmann; Georg Roth; Mariann Gyöngyösi; Bruno Karl Podesser; Hendrik Jan Ankersmit
Journal:  Basic Res Cardiol       Date:  2011-03-17       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.